AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30795718 — intervention group
Group type: COMPARATOR
Intervention: No-message control group
Number of subjects: 303
Study 30222631 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (7.5mg, 300,000 IU; 15mL)
Number of subjects: 79
Study 30222631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 27633076 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurodevelopmental treatment (NDT) + Vestibular training (VR)
Number of subjects: 14
Study 27633076 — intervention group
Group type: COMPARATOR
Intervention: Neurodevelopmental treatment (NDT)
Number of subjects: 14
Study 27633076 — intervention group
Group type: COMPARATOR
Intervention: Vestibular training (VR)
Number of subjects: 14
Study 25171666 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation treatment in addition to physical therapy (5 days per week for 3 weeks)
Number of subjects: 60
Study 25171666 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (hot pack, facial expression exercises, and massage)
Number of subjects: 60
Study 23176373 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser heat therapy (LHT)
Number of subjects: 38
Study 23176373 — intervention group
Group type: COMPARATOR
Intervention: Sham heat therapy (SHT)
Number of subjects: 38
Study 21995469 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron (5 mg)
Number of subjects: 100
Study 21995469 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (10 mg)
Number of subjects: 100
Study 18331945 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% chlorhexidine varnish (40%CHX)
Number of subjects: 60
Study 18331945 — intervention group
Group type: COMPARATOR
Intervention: 1% chlorhexidine/1% thymol varnish (1%CHX)
Number of subjects: 60
Study 17274493 — intervention group
Group type: EXPERIMENTAL
Intervention: Menatetrenone (vitamin K2)
Number of subjects: 0
Study 17274493 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with bisphosphonates and menatetrenone
Number of subjects: 0
Study 17274493 — intervention group
Group type: EXPERIMENTAL
Intervention: Menatetrenone
Number of subjects: 0
Study 17274493 — intervention group
Group type: COMPARATOR
Intervention: Bisphosphonates
Number of subjects: 0
Study 12812815 — intervention group
Group type: EXPERIMENTAL
Intervention: High-level intervention group (interactive group sessions and mailed modules)
Number of subjects: 0
Study 12812815 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level intervention group (mailed modules only)
Number of subjects: 0
Study 12812815 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 10820872 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT) with 3 sessions of low energy ESWT (2000 impulses, energy flux density 0.07-0.09 mJ/mm2)
Number of subjects: 272
Study 10820872 — intervention group
Group type: COMPARATOR
Intervention: Sham-ESWT (placebo control)
Number of subjects: 272
Study 9029412 — intervention group
Group type: EXPERIMENTAL
Intervention: Gly‐340‐Ser variant
Number of subjects: 42
Study 9029412 — intervention group
Group type: EXPERIMENTAL
Intervention: 1083T variant
Number of subjects: 42
Study 9029412 — intervention group
Group type: EXPERIMENTAL
Intervention: Ser‐340 variant
Number of subjects: 42
Study 9029412 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study 1814447 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative local therapy
Number of subjects: 0
Study 1814447 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention
Number of subjects: 0
Study 1814447 — intervention group
Group type: COMPARATOR
Intervention: Conservative local treatment
Number of subjects: 0
Study 6881078 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplement
Number of subjects: 40
Study 6881078 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 31973208 — intervention group
Group type: EXPERIMENTAL
Intervention: Champ4life lifestyle intervention
Number of subjects: 94
Study 31048072 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematically expressed criterion for likely cases of alternative classifications
Number of subjects: 0
Study 31048072 — intervention group
Group type: COMPARATOR
Intervention: No computable criterion
Number of subjects: 0
Study 28994676 — intervention group
Group type: EXPERIMENTAL
Intervention: IPPV
Number of subjects: 44
Study 28994676 — intervention group
Group type: COMPARATOR
Intervention: NIPPV
Number of subjects: 44
Study 27022637 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose subperiosteal anaesthesia (0.9 ml of articaine with 0.5% epinephrine)
Number of subjects: 120
Study 27022637 — intervention group
Group type: COMPARATOR
Intervention: High-dose infiltration anaesthesia (7.2 ml of articaine with 0.5% epinephrine)
Number of subjects: 120
Study 24685937 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and mindfulness-based stress management workshop (n=66)
Number of subjects: 120
Study 24685937 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (n=54)
Number of subjects: 120
Study 22644006 — intervention group
Group type: EXPERIMENTAL
Intervention: Transumbilical approach (group A)
Number of subjects: 82
Study 22644006 — intervention group
Group type: COMPARATOR
Intervention: Infra-umbilical approach (group B)
Number of subjects: 82
Study 19384124 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal betamethasone (2x12 mg)
Number of subjects: 63
Study 19384124 — intervention group
Group type: COMPARATOR
Intervention: Control group (no betamethasone)
Number of subjects: 63
Study 17442091 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical zinc oxide 20% ointment
Number of subjects: 44
Study 17442091 — intervention group
Group type: COMPARATOR
Intervention: Salicylic acid 15% + lactic acid 15% ointment
Number of subjects: 44
Study 14767239 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm-crank exercise (40 rpm) in 35 degrees C, 50% RH for 3 x 10-min bouts
Number of subjects: 22
Study 14767239 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy peers)
Number of subjects: 22
Study 12536697 — intervention group
Group type: EXPERIMENTAL
Intervention: Zafirlukast 20 mg twice daily plus inhaled budelade (half quantity of GINA standard), long-acting aminophyllin 0.2 g twice daily, and inhaled salbutamol when necessary
Number of subjects: 0
Study 12536697 — intervention group
Group type: COMPARATOR
Intervention: Inhaled budelade of GINA standard quantity, long-acting aminophyllin 0.2 g twice daily, and inhaled salbutamol when necessary
Number of subjects: 0
Study 12536697 — intervention group
Group type: EXPERIMENTAL
Intervention: Zafirlukast 20 mg twice daily added to standard treatment for stable asthma
Number of subjects: 0
Study 9430083 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg feeding (two eggs daily)
Number of subjects: 161
Study 9430083 — intervention group
Group type: COMPARATOR
Intervention: Egg substitute (control group)
Number of subjects: 161
Study 8306009 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive intervention (early angiography and PTCA)
Number of subjects: 5882
Study 8306009 — intervention group
Group type: COMPARATOR
Intervention: Conservative therapies
Number of subjects: 5882
Study 3121268 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition
Number of subjects: 36
Study 3121268 — intervention group
Group type: EXPERIMENTAL
Intervention: Elemental diet
Number of subjects: 36
Study 3121268 — intervention group
Group type: COMPARATOR
Intervention: Personalized food exclusion diets
Number of subjects: 36
Study 30335720 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Ketogenic Diet (LCKD) (≤50 g or ≤10% daily intake of carbohydrates)
Number of subjects: 14
Study 30335720 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Ketogenic Diet (LCKD)
Number of subjects: 14
Study 30335720 — intervention group
Group type: COMPARATOR
Intervention: Usual Diet (UD) (>250 g daily intake of carbohydrates)
Number of subjects: 14
Study 27756314 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication for behavioural impact (COMBI) strategy
Number of subjects: 761
Study 24401173 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance telephone call ahead of reminder questionnaire (n=390)
Number of subjects: 753
Study 24401173 — intervention group
Group type: COMPARATOR
Intervention: Usual reminder schedule only (n=363)
Number of subjects: 753
Study 23442318 — intervention group
Group type: EXPERIMENTAL
Intervention: AOD use among Coloured women
Number of subjects: 720
Study 23442318 — intervention group
Group type: EXPERIMENTAL
Intervention: AOD use among Black African women
Number of subjects: 720
Study 23442318 — intervention group
Group type: EXPERIMENTAL
Intervention: AOD impairment during last sexual encounter
Number of subjects: 720
Study 23442318 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner AOD impairment
Number of subjects: 720
Study 20097908 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers of children with T1D
Number of subjects: 195
Study 20097908 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers of children with CF
Number of subjects: 195
Study 18411010 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine 70 microg/h (BUP TDS)
Number of subjects: 289
Study 18411010 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 289
Study 15927144 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour therapy (BT) consisting of self-control procedures offered in six sessions
Number of subjects: 28
Study 15927144 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour therapy (BT)
Number of subjects: 28
Study 12645707 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative prophylactic hemodialysis (dialysis group, 21 patients)
Number of subjects: 44
Study 12645707 — intervention group
Group type: COMPARATOR
Intervention: Control group (23 patients, hemodialysis only if postoperative acute renal failure diagnosed)
Number of subjects: 44
Study 10754364 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid infusion
Number of subjects: 20
Study 10754364 — intervention group
Group type: COMPARATOR
Intervention: Control (no amino acid infusion)
Number of subjects: 20
Study 8595829 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver amalgam restorations placed in posterior teeth
Number of subjects: 60
Study 8595829 — intervention group
Group type: COMPARATOR
Intervention: Control group (no amalgam restorations)
Number of subjects: 60
Study 8595829 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (silver amalgam restorations)
Number of subjects: 60
Study 1981000 — intervention group
Group type: EXPERIMENTAL
Intervention: Antacid (80 ml of suspension; Maalox 70) administered on the evening before dosing and again 2 h before and 2 h after breakfast
Number of subjects: 18
Study 7012191 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine maleate, 4 times daily for one week
Number of subjects: 106
Study 7012191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 31467892 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS over the right posterior superior temporal gyrus (pSTG)
Number of subjects: 54
Study 31467892 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS over the right pars triangularis of the posterior inferior frontal gyrus (pIFG)
Number of subjects: 54
Study 31467892 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 54
Study 29385005 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 hours before + immediately before (photobiomodulation therapy [PBMT] applied both 6 hours before and immediately before the test)
Number of subjects: 16
Study 29385005 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediately before (placebo applied 6 hours before and PBMT applied immediately before the test)
Number of subjects: 16
Study 29385005 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 16
Study 29385005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 29385005 — intervention group
Group type: COMPARATOR
Intervention: Immediately before
Number of subjects: 16
Study 27745820 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus carboplatin and pemetrexed
Number of subjects: 123
Study 27745820 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (carboplatin and pemetrexed)
Number of subjects: 123
Study 27745820 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus chemotherapy
Number of subjects: 123
Study 27745820 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 123
Study 25005597 — intervention group
Group type: EXPERIMENTAL
Intervention: Long hospital discharge letter provided immediately
Number of subjects: 59
Study 25005597 — intervention group
Group type: EXPERIMENTAL
Intervention: Short hospital discharge letter provided immediately
Number of subjects: 59
Study 25005597 — intervention group
Group type: EXPERIMENTAL
Intervention: Long hospital discharge letter provided 1 week later
Number of subjects: 59
Study 25005597 — intervention group
Group type: EXPERIMENTAL
Intervention: Short hospital discharge letter provided 1 week later
Number of subjects: 59
Study 22569690 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible cystoscopy (FC)
Number of subjects: 100
Study 22569690 — intervention group
Group type: COMPARATOR
Intervention: Rigid cystoscopy (RC)
Number of subjects: 100
Study 20130232 — intervention group
Group type: EXPERIMENTAL
Intervention: CCR5Delta32 deletion
Number of subjects: 5748
Study 20130232 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-nucleotide polymorphisms (rs1154428, rs6808835, rs6791599) in CCRL2
Number of subjects: 5748
Study 20130232 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 5748
Study 19095138 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized fenofibrate 200 mg/day
Number of subjects: 170
Study 19095138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study 16213291 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak cyclosporine blood levels guided by calculating the area under the curve
Number of subjects: 65
Study 16213291 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine trough levels
Number of subjects: 65
Study 16213291 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak cyclosporine blood levels
Number of subjects: 65
Study 16213291 — intervention group
Group type: EXPERIMENTAL
Intervention: Calculated area under the curve
Number of subjects: 65
Study 16213291 — intervention group
Group type: COMPARATOR
Intervention: Incidence of acute rejection, cyclosporine nephrotoxicity, proteinuria, serum creatinine levels, graft and patient outcomes
Number of subjects: 65
Study 11843722 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mL of 0.5% bupivacaine hydrochloride
Number of subjects: 63
Study 11843722 — intervention group
Group type: COMPARATOR
Intervention: 5 mL of isotonic sodium chloride solution (Control)
Number of subjects: 63
Study 10443523 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissection and suture of the serratus anterior muscle
Number of subjects: 28
Study 10443523 — intervention group
Group type: COMPARATOR
Intervention: Preservation of the serratus anterior muscle
Number of subjects: 28
Study 8847270 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise (70% maximal oxygen consumption x 50 min)
Number of subjects: 24
Study 8847270 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity exercise (40% maximal oxygen consumption x 87 min)
Number of subjects: 24
Study 8847270 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 24
Study 2161328 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 127
Study 2161328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 380614 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofibrate (2 g/day; period B; 2 months)
Number of subjects: 22
Study 380614 — intervention group
Group type: COMPARATOR
Intervention: Placebo (periods A and C, 2 months each)
Number of subjects: 22
Study 6210878 — intervention group
Group type: EXPERIMENTAL
Intervention: Cl2MDP (3200 mg/day)
Number of subjects: 8
Study 6210878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 30690293 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (doxorubicin plus ifosfamide)
Number of subjects: 290
Study 30690293 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 290
Study 30267999 — intervention group
Group type: EXPERIMENTAL
Intervention: FilmArray Respiratory Panel (FilmArray-RP)
Number of subjects: 432
Study 26574195 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interview with significant other (SO)
Number of subjects: 406
Study 26574195 — intervention group
Group type: COMPARATOR
Intervention: Motivational interview without significant other
Number of subjects: 406
Study 24985959 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient orange fragrance
Number of subjects: 56
Study 24985959 — intervention group
Group type: COMPARATOR
Intervention: No fragrance (control)
Number of subjects: 56
Study 21900227 — intervention group
Group type: EXPERIMENTAL
Intervention: Good-quality peripapillary circular OCT scans (global signal strength (SS) ≥ 6); fast retinal nerve fibre layer scan protocol; Stratus OCT.
Number of subjects: 68
Study 21900227 — intervention group
Group type: EXPERIMENTAL
Intervention: Global mean QI, QI SD, and their interaction term in logistic mixed-effects regression modeling.
Number of subjects: 68
Study 21900227 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean QI < 20 or SS < 8.
Number of subjects: 68
Study 20619854 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional ventilation (85% of patients)
Number of subjects: 535
Study 20619854 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer conventional ventilation modes (volume targeted and pressure support)
Number of subjects: 535
Study 20619854 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive end‐expiratory pressure (PEEP)
Number of subjects: 535
Study 17611916 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 L of polyethylene glycol solution with a soft diet on the preceding day and then 1 L of the solution on the day of colonoscopy (split-dose)
Number of subjects: 303
Study 17611916 — intervention group
Group type: COMPARATOR
Intervention: 4 L of polyethylene glycol solution with a soft diet on the day before colonoscopy (single-dose)
Number of subjects: 303
Study 17611916 — intervention group
Group type: EXPERIMENTAL
Intervention: Good compliance (116 in group A, 119 in group B)
Number of subjects: 303
Study 17611916 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor compliance (36 in group A, 32 in group B)
Number of subjects: 303
Study 16083526 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg
Number of subjects: 32
Study 16083526 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 20 mg
Number of subjects: 32
Study 16083526 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg plus Fluvastatin 20 mg
Number of subjects: 32
Study 16083526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 12394229 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol infusion (100‐mL 20% mannitol)
Number of subjects: 30
Study 12394229 — intervention group
Group type: COMPARATOR
Intervention: 5% dextrose solution (control group)
Number of subjects: 30
Study 10825856 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Tartar Control Plus Whitening Fluoride Toothpaste
Number of subjects: 58
Study 10825856 — intervention group
Group type: COMPARATOR
Intervention: Crest Tartar Control Toothpaste
Number of subjects: 58
Study 7581431 — intervention group
Group type: EXPERIMENTAL
Intervention: intensive training of muscle endurance
Number of subjects: 40
Study 7581431 — intervention group
Group type: EXPERIMENTAL
Intervention: muscle training including coordination
Number of subjects: 40
Study 2310448 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular injection of bupivacaine (100 mg, 40 mL of 0.25%)
Number of subjects: 101
Study 2310448 — intervention group
Group type: COMPARATOR
Intervention: Intraarticular injection of saline
Number of subjects: 101
Study 2310448 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous injection of bupivacaine at the portal sites
Number of subjects: 101
Study 2310448 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intraarticular and subcutaneous injection of bupivacaine
Number of subjects: 101
Study 393441 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG immunotherapy
Number of subjects: 18
Study 393441 — intervention group
Group type: COMPARATOR
Intervention: Surgical excision only
Number of subjects: 18
Study 29553309 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin‐A plus evidence‐based movement training
Number of subjects: 136
Study 29553309 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin‐A alone
Number of subjects: 136
Study 29194242 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential teaching strategy
Number of subjects: 78
Study 29194242 — intervention group
Group type: COMPARATOR
Intervention: Traditional method
Number of subjects: 78
Study 26284906 — intervention group
Group type: EXPERIMENTAL
Intervention: C. militaris (1.5 g/day for 4 weeks)
Number of subjects: 79
Study 26284906 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical capsules filled with microcrystalline cellulose and lactose)
Number of subjects: 79
Study 23118143 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Navigation Intervention (TNI) Group
Number of subjects: 945
Study 23118143 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Intervention (SI) Group
Number of subjects: 945
Study 23118143 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 945
Study 21969008 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmonella typhi vaccine
Number of subjects: 20
Study 21969008 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokines (interleukin‐6/tumor necrosis factor‐α/lipopolysaccharide)
Number of subjects: 20
Study 21969008 — intervention group
Group type: COMPARATOR
Intervention: GCH1 X haplotype (XX)
Number of subjects: 20
Study 21969008 — intervention group
Group type: EXPERIMENTAL
Intervention: GCH1 OO haplotype (OO)
Number of subjects: 20
Study 18223378 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard infant formula supplemented with IGF‐1 (10 microg/100 mL of formula)
Number of subjects: 60